WHO ICTRP trial
Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis.
JPRN-jRCT2080220803 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220803 |
|---|---|
| Public title | Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis. |
| Scientific title | Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis. |
| Primary sponsor | JAPAN TABACCO INC. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Primary Osteoporosis |
| Interventions | investigational material(s) Generic name etc : JTT-305 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Oral control material(s)… |
| Registration date | Aug 14, 2009 |
| Target size | 320 |
| Secondary IDs | JapicCTI-090832 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: